Application of the amplification-free sers-based crispr/cas12a platform in the identification of sars-cov-2 from clinical samples

HIGHLIGHTS

• who: Jiajie Liang from the (UNIVERSITY) have published the article: Application of the amplification-free SERS-based CRISPR/Cas12a platform in the identification of SARS-CoV-2 from clinical samples, in the Journal: (JOURNAL) of January/17,/2020
• what: The global COVID-19 pandemic highlights the need for rapid, economical, and easy-to-use diagnostic kits, which would contribute to early decisions on disease-control strategies and management of patient treatments.
• how: Su2011CRISPR for the detection of SARSu2011CoVu20112 from clinical samples Data were analysed with the GraphPad Prism 8. As a proof of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.